Cardiff Oncology (CRDF) Receivables - Other (2022 - 2025)
Cardiff Oncology (CRDF) has disclosed Receivables - Other for 4 consecutive years, with $300000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 25.0% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, down 25.0% year-over-year, with the annual reading at $300000.0 for FY2025, 25.0% down from the prior year.
- Receivables - Other hit $300000.0 in Q4 2025 for Cardiff Oncology, down from $400000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $600000.0 in Q4 2023 to a low of $300000.0 in Q4 2025.
- Historically, Receivables - Other has averaged $450000.0 across 4 years, with a median of $450000.0 in 2022.
- Biggest five-year swings in Receivables - Other: grew 20.0% in 2023 and later crashed 33.33% in 2024.
- Year by year, Receivables - Other stood at $500000.0 in 2022, then rose by 20.0% to $600000.0 in 2023, then crashed by 33.33% to $400000.0 in 2024, then dropped by 25.0% to $300000.0 in 2025.
- Business Quant data shows Receivables - Other for CRDF at $300000.0 in Q4 2025, $400000.0 in Q4 2024, and $600000.0 in Q4 2023.